Brief: Enlivex Therapeutics Ltd Says Qtrly Net Loss $3.4 Mln
22/11/2021 13:16
Nov 22 (Reuters) - Enlivex Therapeutics Ltd ENLV.TA :
* ENLIVEX THERAPEUTICS LTD - QTRLY NET LOSS WAS $3.4 MILLION
* ENLIVEX ANNOUNCES THIRD QUARTER 2021 FINANCIAL RESULTS AND
PROVIDES A BUSINESS UPDATE
* ENLIVEX THERAPEUTICS LTD - EXISTING CASH, CASH EQUIVALENTS
WILL
BE SUFFICIENT TO FUND OPERATING EXPENSES, CAPITAL EXPENDITURE
THROUGH YEAR-END 2023
Further company coverage: ENLV.TA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enlivex
See all newsBrief: Enlivex Ltd Registers Up To 23,333,333 Ordinary Shares For Resale By Selling Shareholder
Brief: Enlivex Announces Second Regulatory Approval For Phase 2B Trial Of Allocetra In Age-Related Primary Moderate-To-Severe Knee Osteoarthritis
Brief: Enlivex Therapeutics Files For Offering Of Up To $299.6 Mln Of Ordinary Shares
Brief: Enlivex Announces Positive 6-Month Topline Data For Patients with Knee Osteoarthritis
Brief: Enlivex Files Patent for Allocetra Use in Osteoarthritis Treatment